Selected references

Alternate TextBack

COVID-19 VACCINE FACILITY TO CHINA

7.5 months from start of detailed design to hand-over! Covid-19 vaccine manufacturing facility delivered in record time.

  • Delivered to: China
  • Completed: 2021
  • Size: 5 floors modular building. Area 6,000 sqm.
  • Scope: Covid-19 vaccine manufacturing facility for mRNA vaccine and the adenovirus vaccine production, including aseptic filling of the vaccines.
  • Delivered to: China
  • Completed: 2021
  • Size: 5 floors modular building. Area 6,000 sqm.
  • Scope: Covid-19 vaccine manufacturing facility for mRNA vaccine and the adenovirus vaccine production, including aseptic filling of the vaccines.
arrow

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies